Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...

A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD), reports a new study at Columbia ...

In a study published in Nature Communications, Mayo Clinic researchers have identified specific DNA-level changes in the ...

POTOMAC, MD / ACCESS Newswire / March 18, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, ...

Before the advent of the amyloid hypothesis in the 1990s, the cholinergic hypothesis offered key clues to the etiology of Alzheimer’s disease. Concentrated in the basal forebrain and projecting ...

Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.

Guest columnist Melissa Zapanta Shelton is executive director of the Alzheimer’s Association Cleveland and Greater East Ohio chapters. Currently, 55 million people are living with Alzheimer’s disease ...

The NHS spending watchdog must look again at its decision after drug manufacturers successfully appealed against Nice's ruling that the treatments were not cost-effective ...

WASHINGTON, D.C. -- A major drug company is defending itself against accusations it kept promising and possibly life-saving data secret. The Washington Post reports that Pfizer decided against sharing ...

A national program is working to improve how frontline healthcare workers recognize signs of cognitive decline.

The agenda will include learning about the Alzheimer’s Association, the Walk to End Alzheimer’s and how one can get involved. To RSVP, call the local Alzheimer’s Association office at 707-832-4577, ...